Aa
A
A
Close
1707536 tn?1334977677
BMS 78% SVR12 1b Prior Null Responders
"Investigational Hepatitis C Dual DAA Regimen of Daclatasvir and Asunaprevir Achieved SVR12 in 78% of Difficult-to-Treat Genotype 1b Prior Null Responders In Expanded Phase II Study"



http://finance.yahoo.com/news/investigational-hepatitis-c-dual-daa-214500427.html
Cancel
0 Answers
Page 1 of 1
Your Answer
1707536 tn?1334977677
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Recent Activity
317787 tn?1463415842
Blank
Dee1956 commented on Belle313's status
8 hrs ago
Avatar universal
Blank
JCB1606 cautiously optimistic Comment
9 hrs ago
3060903 tn?1398568723
Blank
Nighthawk61 commented on mishymoshymarcy's status
20 hrs ago
Blank
Weight Tracker
Track your weight over time
Start Tracking Now
Top Hepatitis Answerers
683231 tn?1438659664
Blank
Auburn, WA
446474 tn?1446351282
Blank
San Francisco, CA
163305 tn?1333672171
Blank
Rural Mural, CA
1815939 tn?1377995399
Blank
Avatar universal
Blank
317787 tn?1463415842
Blank
DC
Hepatitis C Community Resources
RSS Expert Activity
233488 tn?1310696703
Blank
Marathon Running Done Over Many Yea...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
233488 tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
748543 tn?1463449675
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
683231 tn?1438659664
Blank
Auburn, WA
446474 tn?1446351282
Blank
San Francisco, CA
163305 tn?1333672171
Blank
Rural Mural, CA
1815939 tn?1377995399
Blank
Avatar universal
Blank
317787 tn?1463415842
Blank
DC